World J Mens Health.  2016 Aug;34(2):73-88. 10.5534/wjmh.2016.34.2.73.

Postprostatectomy Erectile Dysfunction: A Review

• Capogrosso P
• Salonia A
• Briganti A
• Montorsi F

• KMID: 2349844
• DOI: http://doi.org/10.5534/wjmh.2016.34.2.73

Abstract

In the current era of the early diagnosis of prostate cancer (PCa) and the development of minimally invasive surgical techniques, erectile dysfunction (ED) represents an important issue, with up to 68% of patients who undergo radical prostatectomy (RP) complaining of postoperative erectile function (EF) impairment. In this context, it is crucial to comprehensively consider all factors possibly associated with the prevention of post-RP ED throughout the entire clinical management of PCa patients. A careful assessment of both oncological and functional baseline characteristics should be carried out for each patient preoperatively. Baseline EF, together with age and the overall burden of comorbidities, has been strongly associated with the chance of post-RP EF recovery. With this goal in mind, internationally validated psychometric instruments are preferable for ensuring proper baseline EF evaluations, and questionnaires should be administered at the proper time before surgery. Careful preoperative counselling is also required, both to respect the patient's wishes and to avoid false expectations regarding eventual recovery of baseline EF. The advent of robotic surgery has led to improvements in the knowledge of prostate surgical anatomy, as reflected by the formal redefinition of nerve-sparing techniques. Overall, comparative studies have shown significantly better EF outcomes for robotic RP than for open techniques, although data from prospective trials have not always been consistent. Preclinical data and several prospective randomized trials have demonstrated the value of treating patients with oral phosphodiesterase 5 inhibitors (PDE5is) after surgery, with the concomitant potential benefit of early re-oxygenation of the erectile tissue, which appears to be crucial for avoiding the eventual penile structural changes that are associated with postoperative neuropraxia and ultimately result in severe ED. For patients who do not properly respond to PDE5is, proper counselling regarding intracavernous treatment should be considered, along with the further possibility of surgical treatment for ED involving the implantation of a penile prosthesis.

Keyword

Erectile dysfunction; Phosphodiesterase 5 inhibitors; Prostatectomy; Prostatic neoplasms; Robotics

MeSH Terms

Comorbidity
Early Diagnosis
Erectile Dysfunction*
Humans
Male
Passive Cutaneous Anaphylaxis
Penile Prosthesis
Phosphodiesterase 5 Inhibitors
Prospective Studies
Prostate
Prostatectomy
Prostatic Neoplasms
Psychometrics
Robotics
Phosphodiesterase 5 Inhibitors

Figure

• 

  Fig. 1 Practical flowchart for preoperative patient assessment. ED: erectile dysfunction.

Reference

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66:7–30. PMID: 26742998.

2. Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014; 370:932–942. PMID: 24597866.

3. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014; 65:124–137. PMID: 24207135.

4. Ficarra V, Novara G, Ahlering TE, Costello A, Eastham JA, Graefen M, et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol. 2012; 62:418–430. PMID: 22749850.

5. Merrill RM, Sloan A. Risk-adjusted incidence rates for prostate cancer in the United States. Prostate. 2012; 72:181–185. PMID: 21538427.

6. Sidana A, Hernandez DJ, Feng Z, Partin AW, Trock BJ, Saha S, et al. Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate. 2012; 72:58–64. PMID: 21520163.

7. Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med. 2010; 7:1687–1698. PMID: 20388165.

8. Schroeck FR, Krupski TL, Sun L, Albala DM, Price MM, Polascik TJ, et al. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol. 2008; 54:785–793. PMID: 18585849.

9. Roethke MC, Lichy MP, Kniess M, Werner MK, Claussen CD, Stenzl A, et al. Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy. World J Urol. 2013; 31:1111–1116. PMID: 22249342.

10. Zorn KC, Gallina A, Hutterer GC, Walz J, Shalhav AL, Zagaja GP, et al. External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy. J Endourol. 2007; 21:1345–1351. PMID: 18042028.

11. de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol. 2016; 70:233–245. PMID: 26215604.

12. Recabal P, Assel M, Musser JE, Caras RJ, Sjoberg DD, Coleman JA, et al. Erectile function recovery after radical prostatectomy in men with high risk features. J Urol. 2016; DOI: 10.1016/j.juro.2016.02.080. [Epub].

13. Gandaglia G, Briganti A, Jackson G, Kloner RA, Montorsi F, Montorsi P, et al. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014; 65:968–978. PMID: 24011423.

14. Salonia A, Castagna G, Saccà A, Ferrari M, Capitanio U, Castiglione F, et al. Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain. J Sex Med. 2012; 9:2708–2715. PMID: 22897643.

15. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol. 2000; 164:1929–1934. PMID: 11061884.

16. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol. 2008; 179:S40–S44. PMID: 18405749.

17. Kumar A, Samavedi S, Bates AS, Giedelman Cuevas CA, Coelho RF, Rocco B, et al. Age stratified comparative analysis of perioperative, functional and oncologic outcomes in patients after robot assisted radical prostatectomy: a propensity score matched study. Eur J Surg Oncol. 2015; 41:837–843. PMID: 25980748.

18. Salomon G, Isbarn H, Budaeus L, Schlomm T, Briganti A, Steuber T, et al. Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy. J Sex Med. 2009; 6:498–504. PMID: 19143908.

19. Teloken PE, Nelson CJ, Karellas M, Stasi J, Eastham J, Scardino PT, et al. Defining the impact of vascular risk factors on erectile function recovery after radical prostatectomy. BJU Int. 2013; 111:653–657. PMID: 22758405.

20. Gandaglia G, Lista G, Fossati N, Suardi N, Gallina A, Moschini M, et al. Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Prostate Cancer Prostatic Dis. 2016; 19:185–190. PMID: 26857023.

21. Briganti A, Gallina A, Suardi N, Capitanio U, Tutolo M, Bianchi M, et al. Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification. J Sex Med. 2010; 7:2521–2531. PMID: 20487236.

22. Novara G, Ficarra V, D'Elia C, Secco S, De Gobbi A, Cavalleri S, et al. Preoperative criteria to select patients for bilateral nerve-sparing robotic-assisted radical prostatectomy. J Sex Med. 2010; 7:839–845. PMID: 19912486.

23. Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, et al. Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery. Eur Urol. 2012; 62:261–272. PMID: 22575909.

24. Salonia A, Zanni G, Gallina A, Saccà A, Sangalli M, Naspro R, et al. Baseline potency in candidates for bilateral nervesparing radical retropubic prostatectomy. Eur Urol. 2006; 50:360–365. PMID: 16413666.

25. Salonia A, Gallina A, Briganti A, Zanni G, Saccà A, Dehò F, et al. Remembered International Index of Erectile Function domain scores are not accurate in assessing preoperative potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. J Sex Med. 2008; 5:677–683. PMID: 18194187.

26. Kim DS, Chung YG, Kim DJ, Park KK, Chung MS, Lee DH, et al. Optimal timing to evaluate prediagnostic baseline erectile function in patients undergoing robot-assisted radical prostatectomy. J Sex Med. 2012; 9:602–607. PMID: 21933350.

27. Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol. 2009; 181:462–471. PMID: 19084865.

28. Deveci S, Gotto GT, Alex B, O'Brien K, Mulhall JP. A survey of patient expectations regarding sexual function following radical prostatectomy. BJU Int. 2015; DOI: 10.1111/bju.13398. [Epub].

29. Skeldon SC, Gani J, Radomski SB. Do patients know their nerve-sparing status after radical prostatectomy? Urology. 2014; 83:1099–1103. PMID: 24767524.

30. Imbimbo C, Creta M, Gacci M, Simonato A, Gontero P, de Cobelli O, et al. Patients' desire to preserve sexual activity and final decision for a nerve-sparing approach: results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study. J Sex Med. 2011; 8:1495–1502. PMID: 21324091.

31. Briganti A, Gallina A, Suardi N, Capitanio U, Tutolo M, Bianchi M, et al. What is the definition of a satisfactory erectile function after bilateral nerve sparing radical prostatectomy. J Sex Med. 2011; 8:1210–1217. PMID: 21269392.

32. Lue TF. Erectile dysfunction. N Engl J Med. 2000; 342:1802–1813. PMID: 10853004.

33. Costello AJ, Brooks M, Cole OJ. Anatomical studies of the neurovascular bundle and cavernosal nerves. BJU Int. 2004; 94:1071–1076. PMID: 15541130.

34. Walsh PC. The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol. 2007; 177:1632–1635. PMID: 17437775.

35. Weyne E, Mulhall J, Albersen M. Molecular pathophysiology of cavernous nerve injury and identification of strategies for nerve function recovery after radical prostatectomy. Curr Drug Targets. 2015; 16:459–473. PMID: 25777276.

36. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol. 2002; 167:1371–1375. PMID: 11832735.

37. Mulhall JP, Secin FP, Guillonneau B. Artery sparing radical prostatectomy--myth or reality? J Urol. 2008; 179:827–831. PMID: 18221962.

38. Bilhim T, Pisco JM, Rio Tinto H, Fernandes L, Pinheiro LC, Furtado A, et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J Vasc Interv Radiol. 2012; 23:1403–1415. PMID: 23101913.

39. Patel VR, Schatloff O, Chauhan S, Sivaraman A, Valero R, Coelho RF, et al. The role of the prostatic vasculature as a landmark for nerve sparing during robot-assisted radical prostatectomy. Eur Urol. 2012; 61:571–576. PMID: 22225830.

40. Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol. 2010; 57:179–192. PMID: 19931974.

41. Secin FP, Touijer K, Mulhall J, Guillonneau B. Anatomy and preservation of accessory pudendal arteries in laparoscopic radical prostatectomy. Eur Urol. 2007; 51:1229–1235. PMID: 16989942.

42. Box GN, Kaplan AG, Rodriguez E Jr, Skarecky DW, Osann KE, Finley DS, et al. Sacrifice of accessory pudendal arteries in normally potent men during robot-assisted radical prostatectomy does not impact potency. J Sex Med. 2010; 7:298–303. PMID: 19912507.

43. John H, Hauri D. Seminal vesicle-sparing radical prostatectomy: a novel concept to restore early urinary continence. Urology. 2000; 55:820–824. PMID: 10840084.

44. Walz J, Epstein JI, Ganzer R, Graefen M, Guazzoni G, Kaouk J, et al. A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimisation of cancer control and preservation of continence and erection in candidates for radical prostatectomy: an update. Eur Urol. 2016; 70:301–311. PMID: 26850969.

45. Alsaid B, Bessede T, Diallo D, Moszkowicz D, Karam I, Benoit G, et al. Division of autonomic nerves within the neurovascular bundles distally into corpora cavernosa and corpus spongiosum components: immunohistochemical confirmation with three-dimensional reconstruction. Eur Urol. 2011; 59:902–909. PMID: 21353738.

46. Ganzer R, Stolzenburg JU, Wieland WF, Bründl J. Anatomic study of periprostatic nerve distribution: immunohistochemical differentiation of parasympathetic and sympathetic nerve fibres. Eur Urol. 2012; 62:1150–1156. PMID: 22469393.

47. Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carroll PR, et al. Best practices in robot-assisted radical prostatectomy: recommendations of the pasadena consensus panel. Eur Urol. 2012; 62:368–381. PMID: 22763081.

48. Tewari AK, Srivastava A, Huang MW, Robinson BD, Shevchuk MM, Durand M, et al. Anatomical grades of nerve sparing: a risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP). BJU Int. 2011; 108:984–992. PMID: 21917101.

49. Tewari AK, Ali A, Metgud S, Theckumparampil N, Srivastava A, Khani F, et al. Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing. World J Urol. 2013; 31:471–480. PMID: 23354288.

50. Schatloff O, Chauhan S, Sivaraman A, Kameh D, Palmer KJ, Patel VR. Anatomic grading of nerve sparing during robot-assisted radical prostatectomy. Eur Urol. 2012; 61:796–802. PMID: 22230713.

51. van der Poel HG, Tillier C, de Blok W, van Muilekom E. Extended nodal dissection reduces sexual function recovery after robot-assisted laparoscopic prostatectomy. J Endourol. 2012; 26:1192–1198. PMID: 22524628.

52. Gandaglia G, Suardi N, Gallina A, Abdollah F, Capitanio U, Salonia A, et al. Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy. J Sex Med. 2012; 9:2187–2194. PMID: 22738395.

53. Dubbelman YD, Dohle GR, Schröder FH. Sexual function before and after radical retropubic prostatectomy: a systematic review of prognostic indicators for a successful outcome. Eur Urol. 2006; 50:711–718. PMID: 16846679.

54. Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009; 55:1037–1063. PMID: 19185977.

55. Kim SC, Song C, Kim W, Kang T, Park J, Jeong IG, et al. Factors determining functional outcomes after radical prostatectomy: robot-assisted versus retropubic. Eur Urol. 2011; 60:413–419. PMID: 21612859.

56. Tewari A, Srivasatava A, Menon M. Members of the VIP Team. A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution. BJU Int. 2003; 92:205–210. PMID: 12887468.

57. Haglind E, Carlsson S, Stranne J, Wallerstedt A, Wilderäng U, Thorsteinsdottir T, et al. Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial. Eur Urol. 2015; 68:216–225. PMID: 25770484.

58. Asimakopoulos AD, Pereira Fraga CT, Annino F, Pasqualetti P, Calado AA, Mugnier C. Randomized comparison between laparoscopic and robot-assisted nerve-sparing radical prostatectomy. J Sex Med. 2011; 8:1503–1512. PMID: 21324093.

59. Di Pierro GB, Baumeister P, Stucki P, Beatrice J, Danuser H, Mattei A. A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre with a limited caseload. Eur Urol. 2011; 59:1–6. PMID: 21035248.

60. Ficarra V, Novara G, Fracalanza S, D'Elia C, Secco S, Iafrate M, et al. A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. BJU Int. 2009; 104:534–539. PMID: 19281468.

61. Stolzenburg JU, Graefen M, Kriegel C, Michl U, Martin Morales A, Pommerville PJ, et al. Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo. BJU Int. 2015; 116:241–251. PMID: 25560809.

62. O'Neil B, Koyama T, Alvarez J, Conwill RM, Albertsen PC, Cooperberg MR, et al. The comparative harms of open and robotic prostatectomy in population based samples. J Urol. 2016; 195:321–329. PMID: 26343985.

63. Alemozaffar M, Sanda M, Yecies D, Mucci LA, Stampfer MJ, Kenfield SA. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the health professionals follow-up study. Eur Urol. 2015; 67:432–438. PMID: 24582327.

64. Ong WL, Evans SM, Spelman T, Kearns PA, Murphy DG, Millar JL. Comparison of oncological and health related quality of life (HRQOL) outcomes between open (ORP) and robotic-assisted radical prostatectomy (RARP) for localized prostate cancer - findings from the population-based Victorian Prostate Cancer Registry (PCR). BJU Int. 2015; DOI: 10.1111/bju.13380. [Epub].

65. Magheli A, Busch J, Leva N, Schrader M, Deger S, Miller K, et al. Comparison of surgical technique (open vs. laparoscopic) on pathological and long term functional outcomes following radical prostatectomy. BMC Urol. 2014; 14:18. PMID: 24506815.

66. Hatzimouratidis K, Burnett AL, Hatzichristou D, McCullough AR, Montorsi F, Mulhall JP. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur Urol. 2009; 55:334–347. PMID: 18986755.

67. Burnett AL. Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy. Urology. 2003; 61:491–497. PMID: 12639630.

68. Moreland RB. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res. 1998; 10:113–120. PMID: 9647948.

69. Weyne E, Castiglione F, Van der Aa F, Bivalacqua TJ, Albersen M. Landmarks in erectile function recovery after radical prostatectomy. Nat Rev Urol. 2015; 12:289–297. PMID: 25868558.

70. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997; 158:1408–1410. PMID: 9302132.

71. Mulhall JP, Müller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA, et al. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med. 2008; 5:1126–1136. PMID: 18331274.

72. Müller A, Akin-Olugbade Y, Deveci S, Donohue JF, Tal R, Kobylarz KA, et al. The impact of shock wave therapy at varied energy and dose levels on functional and structural changes in erectile tissue. Eur Urol. 2008; 53:635–642. PMID: 17618733.

73. Lagoda G, Jin L, Lehrfeld TJ, Liu T, Burnett AL. FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms. J Sex Med. 2007; 4:908–916. PMID: 17627738.

74. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, et al. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 2008; 101:203–210. PMID: 17888043.

75. Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F, et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res. 2008; 20:479–486. PMID: 18650827.

76. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008; 54:924–931. PMID: 18640769.

77. Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, et al. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo. BJU Int. 2013; 112:844–851. PMID: 23937708.

78. Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol. 2014; 65:587–596. PMID: 24169081.

79. Moncada I, de Bethencourt FR, Lledó-García E, Romero-Otero J, Turbi C, Büttner H, et al. Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy. World J Urol. 2015; 33:1031–1038. PMID: 25155034.

80. Montorsi F, Oelke M, Henneges C, Brock G, Salonia A, d'Anzeo G, et al. Exploratory decision-tree modeling of data from the randomized REACTT trial of tadalafil versus placebo to predict recovery of erectile function after bilateral nerve-sparing radical prostatectomy. Eur Urol. 2016; DOI: 10.1016/j.eururo.2016.02.036. [Epub].

81. Mulhall JP, Burnett AL, Wang R, McVary KT, Moul JW, Bowden CH, et al. A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy. J Urol. 2013; 189:2229–2236. PMID: 23219537.

82. Salonia A, Burnett AL, Graefen M, Hatzimouratidis K, Montorsi F, Mulhall JP, et al. Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic function. Eur Urol. 2012; 62:273–286. PMID: 22575910.

83. Mulhall JP, Bivalacqua TJ, Becher EF. Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy. J Sex Med. 2013; 10:195–203. PMID: 22970890.

84. Polito M, d'Anzeo G, Conti A, Muzzonigro G. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates. BJU Int. 2012; 110:E954–E957. PMID: 23078100.

85. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med. 2005; 2:532–540. PMID: 16422848.

86. Yiou R, Cunin P, de la Taille A, Salomon L, Binhas M, Lingombet O, et al. Sexual rehabilitation and penile pain associated with intracavernous alprostadil after radical prostatectomy. J Sex Med. 2011; 8:575–582. PMID: 20807323.

87. Broderick GA, McGahan JP, Stone AR, White RD. The hemodynamics of vacuum constriction erections: assessment by color Doppler ultrasound. J Urol. 1992; 147:57–61. PMID: 1729552.

88. Köhler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, et al. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int. 2007; 100:858–862. PMID: 17822466.

89. Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res. 2006; 18:77–81. PMID: 16107868.

90. Basal S, Wambi C, Acikel C, Gupta M, Badani K. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function. BJU Int. 2013; 111:658–665. PMID: 23186312.

91. Salonia A, Gallina A, Zanni G, Briganti A, Dehò F, Saccà A, et al. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008; 53:564–570. PMID: 17761385.

92. Hellstrom WJ, Montague DK, Moncada I, Carson C, Minhas S, Faria G, et al. Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med. 2010; 7:501–523. PMID: 20092450.

93. Menard J, Tremeaux JC, Faix A, Pierrevelcin J, Staerman F. Erectile function and sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with vasculogenic erectile dysfunction. J Sex Med. 2011; 8:3479–3486. PMID: 21951645.

94. Levine LA, Becher E, Bella A, Brant W, Kohler T, Martinez-Salamanca JI, et al. Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med. 2016; 13:489–518. PMID: 27045255.

95. Tal R, Jacks LM, Elkin E, Mulhall JP. Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database. J Sex Med. 2011; 8:1797–1804. PMID: 21426495.

96. Deveci S, Martin D, Parker M, Mulhall JP. Penile length alterations following penile prosthesis surgery. Eur Urol. 2007; 51:1128–1131. PMID: 17084508.